nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0897	0.13	CbGbCtD
Fluconazole—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0897	0.13	CbGbCtD
Fluconazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0746	0.108	CbGbCtD
Fluconazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0746	0.108	CbGbCtD
Fluconazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0572	0.0831	CbGbCtD
Fluconazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0565	0.0821	CbGbCtD
Fluconazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0386	0.0561	CbGbCtD
Fluconazole—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0377	0.0547	CbGbCtD
Fluconazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0369	0.0536	CbGbCtD
Fluconazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0329	0.0477	CbGbCtD
Fluconazole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0322	0.0468	CbGbCtD
Fluconazole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0304	0.0442	CbGbCtD
Fluconazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0193	0.028	CbGbCtD
Fluconazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0182	0.0265	CbGbCtD
Fluconazole—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000548	0.0023	CcSEcCtD
Fluconazole—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000547	0.0023	CcSEcCtD
Fluconazole—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000547	0.00229	CcSEcCtD
Fluconazole—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000546	0.00229	CcSEcCtD
Fluconazole—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00229	CcSEcCtD
Fluconazole—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00229	CcSEcCtD
Fluconazole—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000545	0.00229	CcSEcCtD
Fluconazole—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000542	0.00227	CcSEcCtD
Fluconazole—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000538	0.00226	CcSEcCtD
Fluconazole—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000538	0.00226	CcSEcCtD
Fluconazole—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000537	0.00225	CcSEcCtD
Fluconazole—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000534	0.00224	CcSEcCtD
Fluconazole—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000531	0.00223	CcSEcCtD
Fluconazole—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000528	0.00221	CcSEcCtD
Fluconazole—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.00219	CcSEcCtD
Fluconazole—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.00219	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.00218	CcSEcCtD
Fluconazole—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00217	CcSEcCtD
Fluconazole—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.00216	CcSEcCtD
Fluconazole—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00216	CcSEcCtD
Fluconazole—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00216	CcSEcCtD
Fluconazole—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.00216	CcSEcCtD
Fluconazole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000508	0.00213	CcSEcCtD
Fluconazole—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000508	0.00213	CcSEcCtD
Fluconazole—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00213	CcSEcCtD
Fluconazole—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00213	CcSEcCtD
Fluconazole—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000506	0.00212	CcSEcCtD
Fluconazole—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00212	CcSEcCtD
Fluconazole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00212	CcSEcCtD
Fluconazole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00212	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.00212	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000504	0.00212	CcSEcCtD
Fluconazole—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.0021	CcSEcCtD
Fluconazole—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000502	0.0021	CcSEcCtD
Fluconazole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00209	CcSEcCtD
Fluconazole—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00208	CcSEcCtD
Fluconazole—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00208	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00207	CcSEcCtD
Fluconazole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00207	CcSEcCtD
Fluconazole—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000492	0.00206	CcSEcCtD
Fluconazole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.00204	CcSEcCtD
Fluconazole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000487	0.00204	CcSEcCtD
Fluconazole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00204	CcSEcCtD
Fluconazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00201	CcSEcCtD
Fluconazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.00201	CcSEcCtD
Fluconazole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000477	0.002	CcSEcCtD
Fluconazole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.002	CcSEcCtD
Fluconazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.002	CcSEcCtD
Fluconazole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000477	0.002	CcSEcCtD
Fluconazole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00199	CcSEcCtD
Fluconazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00198	CcSEcCtD
Fluconazole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00198	CcSEcCtD
Fluconazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000471	0.00198	CcSEcCtD
Fluconazole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00197	CcSEcCtD
Fluconazole—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000468	0.00196	CcSEcCtD
Fluconazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000468	0.00196	CcSEcCtD
Fluconazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00196	CcSEcCtD
Fluconazole—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Fluconazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00194	CcSEcCtD
Fluconazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00193	CcSEcCtD
Fluconazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000453	0.0019	CcSEcCtD
Fluconazole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000452	0.00189	CcSEcCtD
Fluconazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00189	CcSEcCtD
Fluconazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00187	CcSEcCtD
Fluconazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00186	CcSEcCtD
Fluconazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00186	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00186	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00186	CcSEcCtD
Fluconazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00185	CcSEcCtD
Fluconazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00185	CcSEcCtD
Fluconazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00184	CcSEcCtD
Fluconazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000438	0.00184	CcSEcCtD
Fluconazole—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000436	0.00183	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00182	CcSEcCtD
Fluconazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000433	0.00182	CcSEcCtD
Fluconazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.00182	CcSEcCtD
Fluconazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000431	0.00181	CcSEcCtD
Fluconazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000429	0.0018	CcSEcCtD
Fluconazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000429	0.0018	CcSEcCtD
Fluconazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000428	0.0018	CcSEcCtD
Fluconazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000427	0.00179	CcSEcCtD
Fluconazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00178	CcSEcCtD
Fluconazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000423	0.00177	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00176	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00176	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00042	0.00572	CbGpPWpGaD
Fluconazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00176	CcSEcCtD
Fluconazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00176	CcSEcCtD
Fluconazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00176	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00176	CcSEcCtD
Fluconazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00175	CcSEcCtD
Fluconazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00175	CcSEcCtD
Fluconazole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00175	CcSEcCtD
Fluconazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00175	CcSEcCtD
Fluconazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00174	CcSEcCtD
Fluconazole—CYP11B1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000414	0.00565	CbGpPWpGaD
Fluconazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00173	CcSEcCtD
Fluconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000412	0.00562	CbGpPWpGaD
Fluconazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00173	CcSEcCtD
Fluconazole—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000411	0.00561	CbGpPWpGaD
Fluconazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00172	CcSEcCtD
Fluconazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00171	CcSEcCtD
Fluconazole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00171	CcSEcCtD
Fluconazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000407	0.00171	CcSEcCtD
Fluconazole—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000405	0.00552	CbGpPWpGaD
Fluconazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.0017	CcSEcCtD
Fluconazole—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000404	0.0017	CcSEcCtD
Fluconazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00169	CcSEcCtD
Fluconazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00169	CcSEcCtD
Fluconazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000401	0.00168	CcSEcCtD
Fluconazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000401	0.00168	CcSEcCtD
Fluconazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000401	0.00168	CcSEcCtD
Fluconazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00168	CcSEcCtD
Fluconazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00167	CcSEcCtD
Fluconazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00167	CcSEcCtD
Fluconazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00167	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Fluconazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00166	CcSEcCtD
Fluconazole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00165	CcSEcCtD
Fluconazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00165	CcSEcCtD
Fluconazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00164	CcSEcCtD
Fluconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000389	0.0053	CbGpPWpGaD
Fluconazole—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000388	0.00529	CbGpPWpGaD
Fluconazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00162	CcSEcCtD
Fluconazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00162	CcSEcCtD
Fluconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000385	0.00525	CbGpPWpGaD
Fluconazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00161	CcSEcCtD
Fluconazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00161	CcSEcCtD
Fluconazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00161	CcSEcCtD
Fluconazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00161	CcSEcCtD
Fluconazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000384	0.00161	CcSEcCtD
Fluconazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.0016	CcSEcCtD
Fluconazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00159	CcSEcCtD
Fluconazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.00159	CcSEcCtD
Fluconazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00159	CcSEcCtD
Fluconazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00159	CcSEcCtD
Fluconazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000378	0.00158	CcSEcCtD
Fluconazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00158	CcSEcCtD
Fluconazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00158	CcSEcCtD
Fluconazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000376	0.00158	CcSEcCtD
Fluconazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00158	CcSEcCtD
Fluconazole—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000373	0.00509	CbGpPWpGaD
Fluconazole—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000372	0.00507	CbGpPWpGaD
Fluconazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00153	CcSEcCtD
Fluconazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00152	CcSEcCtD
Fluconazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00152	CcSEcCtD
Fluconazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Fluconazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Fluconazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.0015	CcSEcCtD
Fluconazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.0015	CcSEcCtD
Fluconazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000357	0.0015	CcSEcCtD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000355	0.00484	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000355	0.00484	CbGpPWpGaD
Fluconazole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00149	CcSEcCtD
Fluconazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00147	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00035	0.00477	CbGpPWpGaD
Fluconazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00146	CcSEcCtD
Fluconazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00146	CcSEcCtD
Fluconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000349	0.00475	CbGpPWpGaD
Fluconazole—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000349	0.00475	CbGpPWpGaD
Fluconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000347	0.00473	CbGpPWpGaD
Fluconazole—CYP11B1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000345	0.00471	CbGpPWpGaD
Fluconazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00144	CcSEcCtD
Fluconazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00144	CcSEcCtD
Fluconazole—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000344	0.00469	CbGpPWpGaD
Fluconazole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000344	0.00144	CcSEcCtD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000342	0.00467	CbGpPWpGaD
Fluconazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00143	CcSEcCtD
Fluconazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00142	CcSEcCtD
Fluconazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00141	CcSEcCtD
Fluconazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.0046	CbGpPWpGaD
Fluconazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000333	0.0014	CcSEcCtD
Fluconazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.0014	CcSEcCtD
Fluconazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00138	CcSEcCtD
Fluconazole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00138	CcSEcCtD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000327	0.00446	CbGpPWpGaD
Fluconazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00137	CcSEcCtD
Fluconazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00136	CcSEcCtD
Fluconazole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000324	0.00441	CbGpPWpGaD
Fluconazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00135	CcSEcCtD
Fluconazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00135	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000322	0.00439	CbGpPWpGaD
Fluconazole—CYP11B1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000317	0.00433	CbGpPWpGaD
Fluconazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00132	CcSEcCtD
Fluconazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00132	CcSEcCtD
Fluconazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00132	CcSEcCtD
Fluconazole—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00031	0.00423	CbGpPWpGaD
Fluconazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00031	0.0013	CcSEcCtD
Fluconazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.0013	CcSEcCtD
Fluconazole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000307	0.00418	CbGpPWpGaD
Fluconazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00129	CcSEcCtD
Fluconazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00129	CcSEcCtD
Fluconazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00129	CcSEcCtD
Fluconazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00129	CcSEcCtD
Fluconazole—CYP11B1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000305	0.00416	CbGpPWpGaD
Fluconazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00128	CcSEcCtD
Fluconazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00128	CcSEcCtD
Fluconazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00127	CcSEcCtD
Fluconazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00127	CcSEcCtD
Fluconazole—CYP11B1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000301	0.0041	CbGpPWpGaD
Fluconazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00126	CcSEcCtD
Fluconazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00126	CcSEcCtD
Fluconazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.00126	CcSEcCtD
Fluconazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000299	0.00125	CcSEcCtD
Fluconazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.00124	CcSEcCtD
Fluconazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00123	CcSEcCtD
Fluconazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.00122	CcSEcCtD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.00029	0.00396	CbGpPWpGaD
Fluconazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00122	CcSEcCtD
Fluconazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00122	CcSEcCtD
Fluconazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00121	CcSEcCtD
Fluconazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00121	CcSEcCtD
Fluconazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00121	CcSEcCtD
Fluconazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00121	CcSEcCtD
Fluconazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00119	CcSEcCtD
Fluconazole—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000283	0.00386	CbGpPWpGaD
Fluconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00385	CbGpPWpGaD
Fluconazole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000282	0.00385	CbGpPWpGaD
Fluconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000281	0.00383	CbGpPWpGaD
Fluconazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00117	CcSEcCtD
Fluconazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.00117	CcSEcCtD
Fluconazole—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000274	0.00374	CbGpPWpGaD
Fluconazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00115	CcSEcCtD
Fluconazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.00114	CcSEcCtD
Fluconazole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.0037	CbGpPWpGaD
Fluconazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00113	CcSEcCtD
Fluconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00366	CbGpPWpGaD
Fluconazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00111	CcSEcCtD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000265	0.00361	CbGpPWpGaD
Fluconazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00111	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000257	0.00351	CbGpPWpGaD
Fluconazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.00107	CcSEcCtD
Fluconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000254	0.00346	CbGpPWpGaD
Fluconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000252	0.00344	CbGpPWpGaD
Fluconazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00106	CcSEcCtD
Fluconazole—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00105	CcSEcCtD
Fluconazole—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00025	0.00341	CbGpPWpGaD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000249	0.00339	CbGpPWpGaD
Fluconazole—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000249	0.00339	CbGpPWpGaD
Fluconazole—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000246	0.00335	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000245	0.00335	CbGpPWpGaD
Fluconazole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00103	CcSEcCtD
Fluconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000245	0.00333	CbGpPWpGaD
Fluconazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00102	CcSEcCtD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000241	0.00329	CbGpPWpGaD
Fluconazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.001	CcSEcCtD
Fluconazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000999	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000237	0.00323	CbGpPWpGaD
Fluconazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.000993	CcSEcCtD
Fluconazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000991	CcSEcCtD
Fluconazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000985	CcSEcCtD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000235	0.0032	CbGpPWpGaD
Fluconazole—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000946	CcSEcCtD
Fluconazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.00307	CbGpPWpGaD
Fluconazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000914	CcSEcCtD
Fluconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00296	CbGpPWpGaD
Fluconazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000911	CcSEcCtD
Fluconazole—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00091	CcSEcCtD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.000216	0.00295	CbGpPWpGaD
Fluconazole—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000905	CcSEcCtD
Fluconazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000214	0.0009	CcSEcCtD
Fluconazole—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000888	CcSEcCtD
Fluconazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000885	CcSEcCtD
Fluconazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000878	CcSEcCtD
Fluconazole—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00282	CbGpPWpGaD
Fluconazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.0028	CbGpPWpGaD
Fluconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00279	CbGpPWpGaD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.00278	CbGpPWpGaD
Fluconazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000853	CcSEcCtD
Fluconazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00085	CcSEcCtD
Fluconazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000838	CcSEcCtD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000199	0.00272	CbGpPWpGaD
Fluconazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.00272	CbGpPWpGaD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000832	CcSEcCtD
Fluconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000198	0.0027	CbGpPWpGaD
Fluconazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000828	CcSEcCtD
Fluconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00266	CbGpPWpGaD
Fluconazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000815	CcSEcCtD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00262	CbGpPWpGaD
Fluconazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000804	CcSEcCtD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000188	0.00256	CbGpPWpGaD
Fluconazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000788	CcSEcCtD
Fluconazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00078	CcSEcCtD
Fluconazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000777	CcSEcCtD
Fluconazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000766	CcSEcCtD
Fluconazole—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00018	0.00245	CbGpPWpGaD
Fluconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00242	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000178	0.00242	CbGpPWpGaD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00239	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000175	0.00239	CbGpPWpGaD
Fluconazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000732	CcSEcCtD
Fluconazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000731	CcSEcCtD
Fluconazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000727	CcSEcCtD
Fluconazole—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000173	0.00235	CbGpPWpGaD
Fluconazole—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000172	0.00235	CbGpPWpGaD
Fluconazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000722	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00017	0.00232	CbGpPWpGaD
Fluconazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000707	CcSEcCtD
Fluconazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000699	CcSEcCtD
Fluconazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000697	CcSEcCtD
Fluconazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000697	CcSEcCtD
Fluconazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000693	CcSEcCtD
Fluconazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000693	CcSEcCtD
Fluconazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000165	0.00225	CbGpPWpGaD
Fluconazole—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000687	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000163	0.00222	CbGpPWpGaD
Fluconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.0022	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.0022	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000161	0.00219	CbGpPWpGaD
Fluconazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00217	CbGpPWpGaD
Fluconazole—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000158	0.00216	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GC—chronic obstructive pulmonary disease	0.000158	0.00216	CbGpPWpGaD
Fluconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00215	CbGpPWpGaD
Fluconazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000662	CcSEcCtD
Fluconazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000657	CcSEcCtD
Fluconazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000657	CcSEcCtD
Fluconazole—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000156	0.00213	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000154	0.0021	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000153	0.00208	CbGpPWpGaD
Fluconazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000638	CcSEcCtD
Fluconazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000635	CcSEcCtD
Fluconazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000635	CcSEcCtD
Fluconazole—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00205	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00204	CbGpPWpGaD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00202	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00201	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000147	0.002	CbGpPWpGaD
Fluconazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00198	CbGpPWpGaD
Fluconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.00196	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000143	0.00194	CbGpPWpGaD
Fluconazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000592	CcSEcCtD
Fluconazole—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000139	0.00189	CbGpPWpGaD
Fluconazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000577	CcSEcCtD
Fluconazole—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000137	0.00187	CbGpPWpGaD
Fluconazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000568	CcSEcCtD
Fluconazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00055	CcSEcCtD
Fluconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00178	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000127	0.00173	CbGpPWpGaD
Fluconazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000531	CcSEcCtD
Fluconazole—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000125	0.00171	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000125	0.0017	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000123	0.00168	CbGpPWpGaD
Fluconazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000511	CcSEcCtD
Fluconazole—Rash—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000507	CcSEcCtD
Fluconazole—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000121	0.00165	CbGpPWpGaD
Fluconazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000506	CcSEcCtD
Fluconazole—Headache—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000503	CcSEcCtD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00012	0.00164	CbGpPWpGaD
Fluconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.0016	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.0016	CbGpPWpGaD
Fluconazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00158	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00157	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000114	0.00156	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.00155	CbGpPWpGaD
Fluconazole—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000477	CcSEcCtD
Fluconazole—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000113	0.00154	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00148	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.00146	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00144	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00142	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.77e-05	0.00133	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.63e-05	0.00131	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.5e-05	0.00129	CbGpPWpGaD
Fluconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.5e-05	0.00129	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.91e-05	0.00121	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.85e-05	0.00121	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	8.8e-05	0.0012	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.78e-05	0.0012	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	8.73e-05	0.00119	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.73e-05	0.00119	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.66e-05	0.00118	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.64e-05	0.00118	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.54e-05	0.00116	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.44e-05	0.00115	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.39e-05	0.00114	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.36e-05	0.00114	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.28e-05	0.00113	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.26e-05	0.00113	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.25e-05	0.00113	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.07e-05	0.0011	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8e-05	0.00109	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.96e-05	0.00109	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.96e-05	0.00109	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.79e-05	0.00106	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	7.78e-05	0.00106	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.65e-05	0.00104	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.55e-05	0.00103	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.24e-05	0.000986	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.18e-05	0.000979	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.15e-05	0.000975	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.94e-05	0.000947	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.85e-05	0.000934	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.75e-05	0.00092	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.59e-05	0.000898	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.56e-05	0.000894	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	6.15e-05	0.000839	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.13e-05	0.000835	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.99e-05	0.000816	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.91e-05	0.000805	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.79e-05	0.00079	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.78e-05	0.000788	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.71e-05	0.000779	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	5.63e-05	0.000767	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.5e-05	0.00075	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.32e-05	0.000726	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.25e-05	0.000716	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.23e-05	0.000713	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.22e-05	0.000711	CbGpPWpGaD
Fluconazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.05e-05	0.000688	CbGpPWpGaD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.98e-05	0.000678	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.81e-05	0.000656	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.47e-05	0.00061	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.43e-05	0.000605	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.39e-05	0.000598	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.36e-05	0.000595	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.35e-05	0.000593	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.25e-05	0.00058	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.25e-05	0.000579	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.2e-05	0.000573	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.08e-05	0.000556	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.06e-05	0.000553	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.04e-05	0.000551	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.04e-05	0.000551	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.97e-05	0.000541	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.95e-05	0.000538	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.84e-05	0.000523	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.69e-05	0.000503	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—ALB—chronic obstructive pulmonary disease	3.55e-05	0.000483	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.53e-05	0.000482	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.53e-05	0.000481	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.39e-05	0.000462	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.39e-05	0.000461	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.24e-05	0.000441	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.22e-05	0.000439	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.17e-05	0.000433	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.07e-05	0.000419	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.04e-05	0.000414	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.02e-05	0.000412	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.95e-05	0.000402	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.94e-05	0.000401	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.91e-05	0.000396	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.77e-05	0.000378	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.71e-05	0.000369	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.69e-05	0.000367	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.67e-05	0.000363	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.62e-05	0.000357	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.57e-05	0.00035	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.55e-05	0.000348	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.43e-05	0.000332	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.38e-05	0.000324	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.35e-05	0.00032	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.32e-05	0.000316	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.29e-05	0.000313	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.19e-05	0.000299	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.17e-05	0.000295	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000292	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.14e-05	0.000292	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.13e-05	0.00029	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.1e-05	0.000286	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000285	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.03e-05	0.000277	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2e-05	0.000272	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000269	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.96e-05	0.000267	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.95e-05	0.000266	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.93e-05	0.000263	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	0.000253	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.000245	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.75e-05	0.000238	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.67e-05	0.000228	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000225	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000221	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.61e-05	0.000219	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.59e-05	0.000216	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000206	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.5e-05	0.000205	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.48e-05	0.000202	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.48e-05	0.000201	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000196	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.43e-05	0.000195	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	0.000193	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000191	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.38e-05	0.000188	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.000178	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.29e-05	0.000176	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.26e-05	0.000172	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.21e-05	0.000165	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.19e-05	0.000162	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.9e-06	0.000135	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.77e-06	0.000133	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	9.75e-06	0.000133	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	9.52e-06	0.00013	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	9.33e-06	0.000127	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.11e-06	0.000124	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.1e-06	0.000124	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.89e-06	0.000121	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.63e-06	0.000118	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.51e-06	0.000116	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.87e-06	8e-05	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.61e-06	7.65e-05	CbGpPWpGaD
